Rank | Gene Set | Z-score |
---|---|---|
1 | sarcomere organization (GO:0045214) | 6.22729427 |
2 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.13125249 |
3 | cardiac myofibril assembly (GO:0055003) | 5.79455460 |
4 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.19351768 |
5 | myofibril assembly (GO:0030239) | 5.10461591 |
6 | actin-myosin filament sliding (GO:0033275) | 4.60190321 |
7 | muscle filament sliding (GO:0030049) | 4.60190321 |
8 | plasma membrane repair (GO:0001778) | 4.58832284 |
9 | cardiac muscle cell development (GO:0055013) | 4.30192515 |
10 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.24257512 |
11 | cardiac cell development (GO:0055006) | 4.06665323 |
12 | cardiac muscle contraction (GO:0060048) | 3.95879875 |
13 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.89803116 |
14 | actomyosin structure organization (GO:0031032) | 3.89025706 |
15 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.88748859 |
16 | actin-mediated cell contraction (GO:0070252) | 3.79673323 |
17 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.76582255 |
18 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.74785956 |
19 | regulation of relaxation of muscle (GO:1901077) | 3.73050613 |
20 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.71006213 |
21 | heart trabecula formation (GO:0060347) | 3.70644993 |
22 | regulation of actin filament-based movement (GO:1903115) | 3.69474652 |
23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.64136179 |
24 | regulation of cardioblast differentiation (GO:0051890) | 3.56984121 |
25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.53028800 |
26 | barbed-end actin filament capping (GO:0051016) | 3.50440694 |
27 | muscle tissue morphogenesis (GO:0060415) | 3.47633239 |
28 | regulation of sarcomere organization (GO:0060297) | 3.47364483 |
29 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.46341490 |
30 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.46030548 |
31 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.46030548 |
32 | modulation by symbiont of host immune response (GO:0052553) | 3.46030548 |
33 | positive regulation by symbiont of host defense response (GO:0052509) | 3.46030548 |
34 | modulation by symbiont of host defense response (GO:0052031) | 3.46030548 |
35 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.46030548 |
36 | regulation of skeletal muscle contraction (GO:0014819) | 3.43190836 |
37 | cytidine catabolic process (GO:0006216) | 3.42864225 |
38 | cytidine deamination (GO:0009972) | 3.42864225 |
39 | cytidine metabolic process (GO:0046087) | 3.42864225 |
40 | cardiac muscle hypertrophy (GO:0003300) | 3.37753369 |
41 | NIK/NF-kappaB signaling (GO:0038061) | 3.35895575 |
42 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.34045873 |
43 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.32434795 |
44 | cellular response to type I interferon (GO:0071357) | 3.27157040 |
45 | type I interferon signaling pathway (GO:0060337) | 3.27157040 |
46 | response to type I interferon (GO:0034340) | 3.23375104 |
47 | heart process (GO:0003015) | 3.15756957 |
48 | heart contraction (GO:0060047) | 3.15756957 |
49 | surfactant homeostasis (GO:0043129) | 3.15611291 |
50 | striated muscle hypertrophy (GO:0014897) | 3.15553056 |
51 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.15404309 |
52 | negative regulation of interleukin-12 production (GO:0032695) | 3.13994567 |
53 | actin filament-based movement (GO:0030048) | 3.12258709 |
54 | COPI coating of Golgi vesicle (GO:0048205) | 3.11708054 |
55 | Golgi transport vesicle coating (GO:0048200) | 3.11708054 |
56 | basement membrane organization (GO:0071711) | 3.11331146 |
57 | tricarboxylic acid cycle (GO:0006099) | 3.10934563 |
58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.08590318 |
59 | response to peptidoglycan (GO:0032494) | 3.07870693 |
60 | muscle hypertrophy (GO:0014896) | 3.05818500 |
61 | angiogenesis involved in wound healing (GO:0060055) | 3.05326187 |
62 | myeloid dendritic cell differentiation (GO:0043011) | 3.05171786 |
63 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.05082843 |
64 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.04900847 |
65 | establishment of endothelial barrier (GO:0061028) | 3.02539791 |
66 | positive regulation of interferon-alpha production (GO:0032727) | 3.01515263 |
67 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.00248232 |
68 | striated muscle contraction (GO:0006941) | 3.00085431 |
69 | hemidesmosome assembly (GO:0031581) | 2.98397480 |
70 | apoptotic cell clearance (GO:0043277) | 2.98081843 |
71 | regulation of the force of heart contraction (GO:0002026) | 2.93003763 |
72 | regulation of striated muscle contraction (GO:0006942) | 2.92535781 |
73 | regulation of p38MAPK cascade (GO:1900744) | 2.91334028 |
74 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.88778948 |
75 | morphogenesis of an endothelium (GO:0003159) | 2.88647628 |
76 | endothelial tube morphogenesis (GO:0061154) | 2.88647628 |
77 | endothelium development (GO:0003158) | 2.88282228 |
78 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.87387328 |
79 | fibroblast migration (GO:0010761) | 2.86024042 |
80 | adult heart development (GO:0007512) | 2.84543659 |
81 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.84529948 |
82 | adhesion of symbiont to host cell (GO:0044650) | 2.84430877 |
83 | virion attachment to host cell (GO:0019062) | 2.84430877 |
84 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.83679532 |
85 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.83475189 |
86 | protein localization to endosome (GO:0036010) | 2.83175252 |
87 | positive regulation of macrophage cytokine production (GO:0060907) | 2.82667735 |
88 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.82424262 |
89 | negative regulation of heart growth (GO:0061117) | 2.82424262 |
90 | regulation of interferon-alpha production (GO:0032647) | 2.81790194 |
91 | blood vessel maturation (GO:0001955) | 2.81565132 |
92 | fatty acid transmembrane transport (GO:1902001) | 2.78663718 |
93 | regulation of vitamin metabolic process (GO:0030656) | 2.78321629 |
94 | regulation of mononuclear cell migration (GO:0071675) | 2.78300414 |
95 | carnitine shuttle (GO:0006853) | 2.78181896 |
96 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.77131992 |
97 | stress fiber assembly (GO:0043149) | 2.76903341 |
98 | T-helper 1 type immune response (GO:0042088) | 2.76591664 |
99 | venous blood vessel morphogenesis (GO:0048845) | 2.72934732 |
100 | epithelial cell-cell adhesion (GO:0090136) | 2.72402885 |
101 | skin morphogenesis (GO:0043589) | 2.72015885 |
102 | glycosphingolipid catabolic process (GO:0046479) | 2.70898563 |
103 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.70617300 |
104 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.68710083 |
105 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.67556945 |
106 | regulation of endothelial cell differentiation (GO:0045601) | 2.67496075 |
107 | adhesion of symbiont to host (GO:0044406) | 2.66526013 |
108 | polyketide metabolic process (GO:0030638) | 2.66037123 |
109 | doxorubicin metabolic process (GO:0044598) | 2.66037123 |
110 | daunorubicin metabolic process (GO:0044597) | 2.66037123 |
111 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.65712800 |
112 | positive regulation of p38MAPK cascade (GO:1900745) | 2.65184571 |
113 | relaxation of cardiac muscle (GO:0055119) | 2.64146038 |
114 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.64133611 |
115 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.63635137 |
116 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.62384288 |
117 | atrioventricular valve morphogenesis (GO:0003181) | 2.61579753 |
118 | cellular response to zinc ion (GO:0071294) | 2.61511644 |
119 | macrophage activation involved in immune response (GO:0002281) | 2.61295389 |
120 | trabecula morphogenesis (GO:0061383) | 2.61010778 |
121 | immunoglobulin mediated immune response (GO:0016064) | 2.60745983 |
122 | regulation of podosome assembly (GO:0071801) | 2.60534804 |
123 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.60274775 |
124 | phagocytosis, recognition (GO:0006910) | 2.60195865 |
125 | response to muramyl dipeptide (GO:0032495) | 2.59608020 |
126 | negative regulation of potassium ion transport (GO:0043267) | 2.59490421 |
127 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.58266054 |
128 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.58076847 |
129 | wound healing, spreading of epidermal cells (GO:0035313) | 2.56753131 |
130 | glomerular visceral epithelial cell development (GO:0072015) | 2.56617498 |
131 | regulation of early endosome to late endosome transport (GO:2000641) | 2.56352746 |
132 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.56283046 |
133 | germinal center formation (GO:0002467) | 2.55701320 |
134 | regulation of tight junction assembly (GO:2000810) | 2.54319373 |
135 | membrane raft organization (GO:0031579) | 2.54235351 |
136 | cellular response to interferon-alpha (GO:0035457) | 2.53223580 |
137 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.52571156 |
138 | regulation of macrophage cytokine production (GO:0010935) | 2.51767271 |
139 | myeloid dendritic cell activation (GO:0001773) | 2.51665661 |
140 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.51082456 |
141 | regulation of integrin activation (GO:0033623) | 2.50300785 |
142 | glycolipid catabolic process (GO:0019377) | 2.49677874 |
143 | striated muscle atrophy (GO:0014891) | 2.48951760 |
144 | hyaluronan catabolic process (GO:0030214) | 2.48802298 |
145 | cell-substrate junction assembly (GO:0007044) | 2.47681283 |
146 | regulation of sequestering of triglyceride (GO:0010889) | 2.47087154 |
147 | low-density lipoprotein particle clearance (GO:0034383) | 2.45772693 |
148 | cell adhesion mediated by integrin (GO:0033627) | 2.45105333 |
149 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.44208475 |
150 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.43780252 |
151 | wound healing, spreading of cells (GO:0044319) | 2.43594919 |
152 | substrate-dependent cell migration (GO:0006929) | 2.43089505 |
153 | activation of MAPKKK activity (GO:0000185) | 2.39566598 |
154 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.38725686 |
155 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.38686242 |
156 | response to progesterone (GO:0032570) | 2.38247385 |
157 | * pinocytosis (GO:0006907) | 2.37775092 |
158 | modulation by symbiont of host cellular process (GO:0044068) | 2.37766680 |
159 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.37004724 |
160 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.35451107 |
161 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.33887367 |
162 | response to laminar fluid shear stress (GO:0034616) | 2.31904912 |
163 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.31698764 |
164 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.31691868 |
165 | dendritic cell differentiation (GO:0097028) | 2.30765983 |
166 | decidualization (GO:0046697) | 2.28187187 |
167 | regulation of macrophage chemotaxis (GO:0010758) | 2.28056313 |
168 | hypotonic response (GO:0006971) | 2.27599448 |
169 | positive regulation of type 2 immune response (GO:0002830) | 2.25725173 |
170 | positive regulation of receptor recycling (GO:0001921) | 2.25669546 |
171 | detection of other organism (GO:0098543) | 2.25160241 |
172 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.24364634 |
173 | regulation of antigen processing and presentation (GO:0002577) | 2.22578706 |
174 | negative regulation of adherens junction organization (GO:1903392) | 2.21952920 |
175 | negative regulation of focal adhesion assembly (GO:0051895) | 2.21952920 |
176 | negative regulation of cell junction assembly (GO:1901889) | 2.21952920 |
177 | regulation of response to interferon-gamma (GO:0060330) | 2.21632587 |
178 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.21461227 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.40721950 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.38747787 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.01262348 |
4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.00196528 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.81863198 |
6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.54784701 |
7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.48513728 |
8 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.42660062 |
9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.38953510 |
10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.34050353 |
11 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.29462211 |
12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28628047 |
13 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.28331752 |
14 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.19509317 |
15 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.19509317 |
16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.15085338 |
17 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.08759345 |
18 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08181049 |
19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.02758456 |
20 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.00392936 |
21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.98804632 |
22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.97932024 |
23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.93345503 |
24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92496424 |
25 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.90749417 |
26 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.89309353 |
27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.82694083 |
28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.80843121 |
29 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.78970399 |
30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78908760 |
31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.75304109 |
32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.75003818 |
33 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.73233241 |
34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.70627552 |
35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.70207594 |
36 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.65747101 |
37 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.64407849 |
38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.61842152 |
39 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.61385190 |
40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.56874787 |
41 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.55480802 |
42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54383241 |
43 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52922214 |
44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49928923 |
45 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.47264403 |
46 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.47264403 |
47 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.47264403 |
48 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47159820 |
49 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.45991827 |
50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.44603210 |
51 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.43776402 |
52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.43014626 |
53 | * MAF_26560356_Chip-Seq_TH1_Human | 1.42095451 |
54 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.39011652 |
55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38552984 |
56 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.37902815 |
57 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.34517219 |
58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34432575 |
59 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.32863838 |
60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31706631 |
61 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30618387 |
62 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.28783820 |
63 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.27875370 |
64 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.27383081 |
65 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.27057445 |
66 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.26764221 |
67 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.26535304 |
68 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.26080330 |
69 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24858493 |
70 | ATF3_27146783_Chip-Seq_COLON_Human | 1.24672464 |
71 | MYC_22102868_ChIP-Seq_BL_Human | 1.23816950 |
72 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.23276620 |
73 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.21995208 |
74 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.21851345 |
75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21397912 |
76 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.19450742 |
77 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.19450742 |
78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19396176 |
79 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.15969977 |
80 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15868817 |
81 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14629392 |
82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14485283 |
83 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.12915887 |
84 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.12473354 |
85 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.12273353 |
86 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11751492 |
87 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.11308728 |
88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11077604 |
89 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.10970535 |
90 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.10393252 |
91 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.10249367 |
92 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.10038936 |
93 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.10001428 |
94 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08985130 |
95 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.08551063 |
96 | CJUN_26792858_Chip-Seq_BT549_Human | 1.08082212 |
97 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07892196 |
98 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.07644617 |
99 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07462048 |
100 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07261398 |
101 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06811618 |
102 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.03814844 |
103 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03650233 |
104 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.03639922 |
105 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.03564487 |
106 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03521138 |
107 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.03346507 |
108 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02840671 |
109 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.02002877 |
110 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.01872787 |
111 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01618136 |
112 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.01608580 |
113 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01511726 |
114 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.00635363 |
115 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00061385 |
116 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00015869 |
117 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.99810794 |
118 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.99174014 |
119 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.99071839 |
120 | MYB_26560356_Chip-Seq_TH2_Human | 0.98593003 |
121 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97717033 |
122 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.96605079 |
123 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96571623 |
124 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.96418533 |
125 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96025712 |
126 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95946583 |
127 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94555072 |
128 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94373342 |
129 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92926306 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004084_abnormal_cardiac_muscle | 4.71836702 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 3.55685218 |
3 | MP0003828_pulmonary_edema | 3.14308441 |
4 | MP0000751_myopathy | 3.06495040 |
5 | MP0004215_abnormal_myocardial_fiber | 2.94184431 |
6 | MP0004036_abnormal_muscle_relaxation | 2.93380740 |
7 | MP0005330_cardiomyopathy | 2.82699010 |
8 | MP0000749_muscle_degeneration | 2.76814861 |
9 | MP0010368_abnormal_lymphatic_system | 2.75853901 |
10 | MP0003646_muscle_fatigue | 2.72602554 |
11 | MP0004510_myositis | 2.47335754 |
12 | MP0000750_abnormal_muscle_regeneration | 2.44885662 |
13 | MP0008775_abnormal_heart_ventricle | 2.37574246 |
14 | MP0002972_abnormal_cardiac_muscle | 2.34549027 |
15 | MP0004087_abnormal_muscle_fiber | 2.30609243 |
16 | MP0003705_abnormal_hypodermis_morpholog | 2.28761816 |
17 | MP0010630_abnormal_cardiac_muscle | 2.25821559 |
18 | MP0010234_abnormal_vibrissa_follicle | 2.21663361 |
19 | MP0005385_cardiovascular_system_phenoty | 2.19011850 |
20 | MP0001544_abnormal_cardiovascular_syste | 2.19011850 |
21 | MP0003566_abnormal_cell_adhesion | 2.17839594 |
22 | MP0000343_altered_response_to | 2.16831870 |
23 | MP0006138_congestive_heart_failure | 1.97311771 |
24 | MP0005451_abnormal_body_composition | 1.97101840 |
25 | MP0003453_abnormal_keratinocyte_physiol | 1.86586877 |
26 | MP0004947_skin_inflammation | 1.84592271 |
27 | MP0001879_abnormal_lymphatic_vessel | 1.84133749 |
28 | MP0004484_altered_response_of | 1.80792421 |
29 | MP0002138_abnormal_hepatobiliary_system | 1.75310849 |
30 | MP0004130_abnormal_muscle_cell | 1.74148545 |
31 | MP0004272_abnormal_basement_membrane | 1.73947446 |
32 | MP0002106_abnormal_muscle_physiology | 1.72156159 |
33 | MP0005620_abnormal_muscle_contractility | 1.70852829 |
34 | MP0003303_peritoneal_inflammation | 1.68905689 |
35 | MP0003137_abnormal_impulse_conducting | 1.67359564 |
36 | MP0002332_abnormal_exercise_endurance | 1.66950245 |
37 | MP0005167_abnormal_blood-brain_barrier | 1.65883075 |
38 | MP0005257_abnormal_intraocular_pressure | 1.62896617 |
39 | MP0000858_altered_metastatic_potential | 1.60383232 |
40 | MP0003279_aneurysm | 1.60068098 |
41 | MP0008438_abnormal_cutaneous_collagen | 1.58453737 |
42 | MP0005671_abnormal_response_to | 1.57574396 |
43 | MP0000767_abnormal_smooth_muscle | 1.56347746 |
44 | MP0005058_abnormal_lysosome_morphology | 1.56051427 |
45 | MP0003950_abnormal_plasma_membrane | 1.55323058 |
46 | MP0002269_muscular_atrophy | 1.48210137 |
47 | MP0003221_abnormal_cardiomyocyte_apopto | 1.45496111 |
48 | MP0003075_altered_response_to | 1.45191782 |
49 | MP0002127_abnormal_cardiovascular_syste | 1.41684070 |
50 | MP0002796_impaired_skin_barrier | 1.39672390 |
51 | MP0001835_abnormal_antigen_presentation | 1.39160124 |
52 | MP0005165_increased_susceptibility_to | 1.37549152 |
53 | MP0004085_abnormal_heartbeat | 1.34931493 |
54 | MP0002723_abnormal_immune_serum | 1.33941991 |
55 | MP0001958_emphysema | 1.31579881 |
56 | MP0005369_muscle_phenotype | 1.31162599 |
57 | MP0003724_increased_susceptibility_to | 1.31079773 |
58 | MP0000759_abnormal_skeletal_muscle | 1.29083452 |
59 | MP0001849_ear_inflammation | 1.26260666 |
60 | MP0000465_gastrointestinal_hemorrhage | 1.24760474 |
61 | MP0010352_gastrointestinal_tract_polyps | 1.24298801 |
62 | MP0003436_decreased_susceptibility_to | 1.19758351 |
63 | MP0003191_abnormal_cellular_cholesterol | 1.18293093 |
64 | MP0001819_abnormal_immune_cell | 1.18239950 |
65 | MP0003300_gastrointestinal_ulcer | 1.17906779 |
66 | MP0001845_abnormal_inflammatory_respons | 1.17893694 |
67 | MP0002420_abnormal_adaptive_immunity | 1.17190992 |
68 | MP0008260_abnormal_autophagy | 1.16972401 |
69 | MP0003567_abnormal_fetal_cardiomyocyte | 1.15866972 |
70 | MP0000747_muscle_weakness | 1.14237386 |
71 | MP0006082_CNS_inflammation | 1.13537054 |
72 | MP0000266_abnormal_heart_morphology | 1.12388856 |
73 | MP0002128_abnormal_blood_circulation | 1.11054794 |
74 | MP0005166_decreased_susceptibility_to | 1.10917037 |
75 | MP0000733_abnormal_muscle_development | 1.09576360 |
76 | MP0009333_abnormal_splenocyte_physiolog | 1.09413972 |
77 | MP0009840_abnormal_foam_cell | 1.07829401 |
78 | MP0002933_joint_inflammation | 1.07203031 |
79 | MP0001216_abnormal_epidermal_layer | 1.07135766 |
80 | MP0005464_abnormal_platelet_physiology | 1.05939044 |
81 | MP0003448_altered_tumor_morphology | 1.05301865 |
82 | MP0003763_abnormal_thymus_physiology | 1.05200459 |
83 | MP0009764_decreased_sensitivity_to | 1.04390852 |
84 | MP0005623_abnormal_meninges_morphology | 1.04163655 |
85 | MP0004233_abnormal_muscle_weight | 1.04111728 |
86 | MP0003091_abnormal_cell_migration | 1.03866322 |
87 | MP0003941_abnormal_skin_development | 1.00548494 |
88 | MP0002148_abnormal_hypersensitivity_rea | 0.99939100 |
89 | MP0004185_abnormal_adipocyte_glucose | 0.99566816 |
90 | MP0002925_abnormal_cardiovascular_devel | 0.97937394 |
91 | MP0005275_abnormal_skin_tensile | 0.97559259 |
92 | MP0009785_altered_susceptibility_to | 0.96636112 |
93 | MP0008469_abnormal_protein_level | 0.96426051 |
94 | MP0000249_abnormal_blood_vessel | 0.96064348 |
95 | MP0004782_abnormal_surfactant_physiolog | 0.94084028 |
96 | MP0009278_abnormal_bone_marrow | 0.92794673 |
97 | MP0005164_abnormal_response_to | 0.90891722 |
98 | MP0002419_abnormal_innate_immunity | 0.90616317 |
99 | MP0002139_abnormal_hepatobiliary_system | 0.90578370 |
100 | MP0002877_abnormal_melanocyte_morpholog | 0.90481911 |
101 | MP0005023_abnormal_wound_healing | 0.89664068 |
102 | MP0005666_abnormal_adipose_tissue | 0.89459927 |
103 | MP0001614_abnormal_blood_vessel | 0.89062232 |
104 | MP0005310_abnormal_salivary_gland | 0.88945115 |
105 | MP0002060_abnormal_skin_morphology | 0.88416181 |
106 | MP0002006_tumorigenesis | 0.87494945 |
107 | MP0001853_heart_inflammation | 0.86901352 |
108 | MP0005387_immune_system_phenotype | 0.85873404 |
109 | MP0001790_abnormal_immune_system | 0.85873404 |
110 | MP0005025_abnormal_response_to | 0.85834589 |
111 | MP0000604_amyloidosis | 0.85267365 |
112 | MP0001542_abnormal_bone_strength | 0.84648747 |
113 | MP0005501_abnormal_skin_physiology | 0.84602357 |
114 | MP0000716_abnormal_immune_system | 0.84248755 |
115 | MP0001851_eye_inflammation | 0.84211189 |
116 | MP0005390_skeleton_phenotype | 0.83520369 |
117 | MP0008004_abnormal_stomach_pH | 0.83113946 |
118 | MP0001873_stomach_inflammation | 0.82965097 |
119 | MP0005000_abnormal_immune_tolerance | 0.82755027 |
120 | MP0001533_abnormal_skeleton_physiology | 0.81003167 |
121 | MP0005595_abnormal_vascular_smooth | 0.80487362 |
122 | MP0003045_fibrosis | 0.80163201 |
123 | MP0003984_embryonic_growth_retardation | 0.79161290 |
124 | MP0001348_abnormal_lacrimal_gland | 0.78845332 |
125 | MP0002088_abnormal_embryonic_growth/wei | 0.78701481 |
126 | MP0002452_abnormal_antigen_presenting | 0.78181810 |
127 | MP0001727_abnormal_embryo_implantation | 0.74830951 |
128 | MP0005409_darkened_coat_color | 0.74509346 |
129 | MP0003172_abnormal_lysosome_physiology | 0.73772319 |
130 | MP0003806_abnormal_nucleotide_metabolis | 0.73640370 |
131 | MP0005670_abnormal_white_adipose | 0.72874449 |
132 | MP0002429_abnormal_blood_cell | 0.72611449 |
133 | MP0004808_abnormal_hematopoietic_stem | 0.71271407 |
134 | MP0002405_respiratory_system_inflammati | 0.70736455 |
135 | MP0004145_abnormal_muscle_electrophysio | 0.66496567 |
136 | MP0002166_altered_tumor_susceptibility | 0.65968271 |
137 | MP0006054_spinal_hemorrhage | 0.65380411 |
138 | MP0001800_abnormal_humoral_immune | 0.63956496 |
139 | MP0002254_reproductive_system_inflammat | 0.63703748 |
140 | MP0001545_abnormal_hematopoietic_system | 0.63036962 |
141 | MP0005397_hematopoietic_system_phenotyp | 0.63036962 |
142 | MP0005076_abnormal_cell_differentiation | 0.61393631 |
143 | MP0002295_abnormal_pulmonary_circulatio | 0.60993307 |
144 | MP0002998_abnormal_bone_remodeling | 0.60529123 |
145 | MP0005375_adipose_tissue_phenotype | 0.60173206 |
146 | MP0000685_abnormal_immune_system | 0.59341117 |
147 | MP0010155_abnormal_intestine_physiology | 0.59273002 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ventricular tachycardia (HP:0004756) | 6.29815382 |
2 | Sudden death (HP:0001699) | 6.21411246 |
3 | Muscle fiber splitting (HP:0003555) | 5.06917608 |
4 | Atrial fibrillation (HP:0005110) | 4.86595379 |
5 | Right ventricular cardiomyopathy (HP:0011663) | 4.84109417 |
6 | Exercise-induced muscle cramps (HP:0003710) | 4.60181416 |
7 | Primary atrial arrhythmia (HP:0001692) | 4.54972595 |
8 | Increased connective tissue (HP:0009025) | 4.47261749 |
9 | Lipoatrophy (HP:0100578) | 4.38679195 |
10 | Supraventricular arrhythmia (HP:0005115) | 4.37483137 |
11 | Supraventricular tachycardia (HP:0004755) | 4.36842442 |
12 | Hyporeflexia of lower limbs (HP:0002600) | 4.31669054 |
13 | Calf muscle hypertrophy (HP:0008981) | 4.10423086 |
14 | Asymmetric septal hypertrophy (HP:0001670) | 4.03038811 |
15 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.83212732 |
16 | Subaortic stenosis (HP:0001682) | 3.83212732 |
17 | Abnormality of the calf musculature (HP:0001430) | 3.79095654 |
18 | Hematochezia (HP:0002573) | 3.64648304 |
19 | EMG: myopathic abnormalities (HP:0003458) | 3.62807829 |
20 | Difficulty running (HP:0009046) | 3.58039680 |
21 | Syncope (HP:0001279) | 3.51922820 |
22 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.50913852 |
23 | Dilated cardiomyopathy (HP:0001644) | 3.50269563 |
24 | Exercise-induced myalgia (HP:0003738) | 3.16648967 |
25 | Premature rupture of membranes (HP:0001788) | 3.15830692 |
26 | Bundle branch block (HP:0011710) | 3.15509819 |
27 | Spontaneous hematomas (HP:0007420) | 3.10959064 |
28 | Difficulty climbing stairs (HP:0003551) | 3.08906975 |
29 | Ventricular arrhythmia (HP:0004308) | 3.08252661 |
30 | Myoglobinuria (HP:0002913) | 3.05676174 |
31 | Dysostosis multiplex (HP:0000943) | 3.02569363 |
32 | Palpitations (HP:0001962) | 3.01143159 |
33 | Polycythemia (HP:0001901) | 2.92120466 |
34 | Myocardial infarction (HP:0001658) | 2.86843030 |
35 | Cerebral aneurysm (HP:0004944) | 2.84179854 |
36 | Atrioventricular block (HP:0001678) | 2.82921777 |
37 | Distal lower limb muscle weakness (HP:0009053) | 2.77044251 |
38 | Abnormal atrioventricular conduction (HP:0005150) | 2.73129998 |
39 | Prolonged QT interval (HP:0001657) | 2.72931324 |
40 | Vertebral compression fractures (HP:0002953) | 2.71959831 |
41 | Heart block (HP:0012722) | 2.69311871 |
42 | Testicular atrophy (HP:0000029) | 2.69075575 |
43 | Protrusio acetabuli (HP:0003179) | 2.67099414 |
44 | Abnormality of the nasal mucosa (HP:0000433) | 2.65809050 |
45 | Loss of speech (HP:0002371) | 2.63868999 |
46 | Gastrointestinal stroma tumor (HP:0100723) | 2.58510887 |
47 | Increased cerebral lipofuscin (HP:0011813) | 2.55633865 |
48 | Eczematoid dermatitis (HP:0000976) | 2.54238571 |
49 | Recurrent abscess formation (HP:0002722) | 2.42226999 |
50 | Multiple enchondromatosis (HP:0005701) | 2.40641039 |
51 | Systemic lupus erythematosus (HP:0002725) | 2.38853185 |
52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.35573629 |
53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.35573629 |
54 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.35573629 |
55 | Ventricular fibrillation (HP:0001663) | 2.34309738 |
56 | Thick nail (HP:0001805) | 2.34051705 |
57 | Increased variability in muscle fiber diameter (HP:0003557) | 2.32585859 |
58 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.31732329 |
59 | Rhabdomyolysis (HP:0003201) | 2.30693146 |
60 | Mucopolysacchariduria (HP:0008155) | 2.30419955 |
61 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.30419955 |
62 | Tetraparesis (HP:0002273) | 2.29235438 |
63 | Axonal loss (HP:0003447) | 2.29157719 |
64 | Facial diplegia (HP:0001349) | 2.29107268 |
65 | Interstitial pulmonary disease (HP:0006530) | 2.27059191 |
66 | Myotonia (HP:0002486) | 2.26640077 |
67 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.25994396 |
68 | Short nail (HP:0001799) | 2.25362807 |
69 | Nuclear cataract (HP:0100018) | 2.23161944 |
70 | Limb-girdle muscle atrophy (HP:0003797) | 2.21133906 |
71 | Esophageal varix (HP:0002040) | 2.16925033 |
72 | Pulmonary artery stenosis (HP:0004415) | 2.15617063 |
73 | Lymphangioma (HP:0100764) | 2.14267148 |
74 | IgA deficiency (HP:0002720) | 2.12839718 |
75 | Mediastinal lymphadenopathy (HP:0100721) | 2.11595738 |
76 | Aneurysm (HP:0002617) | 2.10581294 |
77 | Atrophic scars (HP:0001075) | 2.09145018 |
78 | Emphysema (HP:0002097) | 2.08847839 |
79 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.07987679 |
80 | Palmoplantar keratoderma (HP:0000982) | 2.07215554 |
81 | Amyloidosis (HP:0011034) | 2.05378795 |
82 | Distal lower limb amyotrophy (HP:0008944) | 2.03055081 |
83 | Arterial tortuosity (HP:0005116) | 2.02634559 |
84 | Cellulitis (HP:0100658) | 2.02418443 |
85 | Sudden cardiac death (HP:0001645) | 2.01650660 |
86 | Natal tooth (HP:0000695) | 2.01322767 |
87 | Cervical subluxation (HP:0003308) | 2.00036684 |
88 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.99597117 |
89 | Spinal rigidity (HP:0003306) | 1.98768575 |
90 | Generalized muscle weakness (HP:0003324) | 1.98523029 |
91 | Hemorrhage of the eye (HP:0011885) | 1.98068730 |
92 | Trismus (HP:0000211) | 1.97589079 |
93 | Areflexia of lower limbs (HP:0002522) | 1.97579856 |
94 | Osteolytic defects of the hand bones (HP:0009699) | 1.97571561 |
95 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.97571561 |
96 | Scapular winging (HP:0003691) | 1.94104326 |
97 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.93811524 |
98 | Onycholysis (HP:0001806) | 1.93032842 |
99 | Abnormal EKG (HP:0003115) | 1.91718043 |
100 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.91305258 |
101 | Spondylolisthesis (HP:0003302) | 1.91212521 |
102 | Orchitis (HP:0100796) | 1.91167606 |
103 | Vascular tortuosity (HP:0004948) | 1.90640455 |
104 | Achilles tendon contracture (HP:0001771) | 1.89351804 |
105 | Type 1 muscle fiber predominance (HP:0003803) | 1.87635950 |
106 | Frequent falls (HP:0002359) | 1.87329926 |
107 | Bone pain (HP:0002653) | 1.87260644 |
108 | Pulmonary infiltrates (HP:0002113) | 1.86666221 |
109 | Thin bony cortex (HP:0002753) | 1.85533942 |
110 | Bone cyst (HP:0012062) | 1.84195037 |
111 | Mesangial abnormality (HP:0001966) | 1.84047418 |
112 | Visceral angiomatosis (HP:0100761) | 1.84043125 |
113 | EMG: neuropathic changes (HP:0003445) | 1.84038351 |
114 | Neck muscle weakness (HP:0000467) | 1.83470656 |
115 | Hypoplastic ischia (HP:0003175) | 1.83338509 |
116 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.83241864 |
117 | Mucosal telangiectasiae (HP:0100579) | 1.83180397 |
118 | Glomerulonephritis (HP:0000099) | 1.82464061 |
119 | Upper motor neuron abnormality (HP:0002127) | 1.81396296 |
120 | Recurrent viral infections (HP:0004429) | 1.81266530 |
121 | Recurrent bacterial skin infections (HP:0005406) | 1.80817694 |
122 | Premature loss of primary teeth (HP:0006323) | 1.79564272 |
123 | Autoimmune thrombocytopenia (HP:0001973) | 1.78255768 |
124 | Polygenic inheritance (HP:0010982) | 1.78111532 |
125 | Broad metatarsal (HP:0001783) | 1.77633686 |
126 | Ridged nail (HP:0001807) | 1.77505925 |
127 | Colitis (HP:0002583) | 1.77436470 |
128 | Congestive heart failure (HP:0001635) | 1.77176119 |
129 | Broad face (HP:0000283) | 1.77143004 |
130 | Neurofibrillary tangles (HP:0002185) | 1.77003472 |
131 | Aortic aneurysm (HP:0004942) | 1.76720145 |
132 | Restrictive lung disease (HP:0002091) | 1.76252131 |
133 | Acrocyanosis (HP:0001063) | 1.76250864 |
134 | Hypertensive crisis (HP:0100735) | 1.76243465 |
135 | Neoplasm of head and neck (HP:0012288) | 1.76121551 |
136 | Esophageal neoplasm (HP:0100751) | 1.76121551 |
137 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.75726154 |
138 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.75726154 |
139 | Abnormality of glycolipid metabolism (HP:0010969) | 1.75726154 |
140 | Vasculitis (HP:0002633) | 1.75289856 |
141 | Hemangiomatosis (HP:0007461) | 1.74767394 |
142 | Left ventricular hypertrophy (HP:0001712) | 1.72876063 |
143 | Myositis (HP:0100614) | 1.72705701 |
144 | Dilatation of the ascending aorta (HP:0005111) | 1.71850904 |
145 | Conjunctival hamartoma (HP:0100780) | 1.71215078 |
146 | Conjunctival telangiectasia (HP:0000524) | 1.70919376 |
147 | Vacuolated lymphocytes (HP:0001922) | 1.70709296 |
148 | Ankle contracture (HP:0006466) | 1.69304056 |
149 | Rapidly progressive (HP:0003678) | 1.69198951 |
150 | Hepatosplenomegaly (HP:0001433) | 1.69197295 |
151 | Flat acetabular roof (HP:0003180) | 1.67623263 |
152 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.67471751 |
153 | Abnormality of macrophages (HP:0004311) | 1.66420765 |
154 | Generalized amyotrophy (HP:0003700) | 1.65199845 |
155 | Abnormality of the Achilles tendon (HP:0005109) | 1.64930293 |
156 | Hyperacusis (HP:0010780) | 1.64755476 |
157 | Neonatal death (HP:0003811) | 1.64725138 |
158 | Aortic dissection (HP:0002647) | 1.64277696 |
159 | Gowers sign (HP:0003391) | 1.64271471 |
160 | Xerostomia (HP:0000217) | 1.63156573 |
161 | Abnormal platelet function (HP:0011869) | 1.63136905 |
162 | Impaired platelet aggregation (HP:0003540) | 1.63136905 |
163 | Ragged-red muscle fibers (HP:0003200) | 1.62552764 |
164 | Joint stiffness (HP:0001387) | 1.62114791 |
165 | Abnormality of complement system (HP:0005339) | 1.61327957 |
166 | Malnutrition (HP:0004395) | 1.60400541 |
167 | Nephritis (HP:0000123) | 1.60135989 |
168 | Skin nodule (HP:0200036) | 1.59701424 |
169 | Apathy (HP:0000741) | 1.59109624 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TTN | 4.44186425 |
2 | TIE1 | 4.05268595 |
3 | TGFBR2 | 3.88924156 |
4 | TRIB3 | 3.09758764 |
5 | ERN1 | 2.93526969 |
6 | PKN2 | 2.73984772 |
7 | PRPF4B | 2.71891355 |
8 | MYLK | 2.54001096 |
9 | DMPK | 2.51674483 |
10 | CDK12 | 2.16243902 |
11 | SMG1 | 2.10833366 |
12 | GRK7 | 2.07852917 |
13 | LMTK2 | 2.00253304 |
14 | KDR | 1.94690513 |
15 | STK10 | 1.80328564 |
16 | OBSCN | 1.78191016 |
17 | RIPK1 | 1.75874337 |
18 | MAP3K13 | 1.72331387 |
19 | MST1R | 1.69880999 |
20 | TESK1 | 1.66435535 |
21 | TAOK2 | 1.62431819 |
22 | ARAF | 1.53462402 |
23 | STK24 | 1.50727982 |
24 | EPHB1 | 1.50582612 |
25 | TYK2 | 1.45908084 |
26 | BLK | 1.44122107 |
27 | PHKG2 | 1.43564636 |
28 | PHKG1 | 1.43564636 |
29 | MAP2K3 | 1.42776104 |
30 | NEK9 | 1.36963342 |
31 | DDR2 | 1.35693057 |
32 | TBK1 | 1.34862049 |
33 | TESK2 | 1.33254107 |
34 | PAK4 | 1.31237444 |
35 | SIK1 | 1.30605717 |
36 | PDK3 | 1.30004691 |
37 | PDK4 | 1.30004691 |
38 | MAP3K3 | 1.28411972 |
39 | LRRK2 | 1.27324136 |
40 | CSF1R | 1.27050140 |
41 | TGFBR1 | 1.21802898 |
42 | TRPM7 | 1.19621766 |
43 | PDK2 | 1.18895482 |
44 | PTK2 | 1.16109498 |
45 | IRAK4 | 1.15369163 |
46 | KIT | 1.15263164 |
47 | MOS | 1.11812962 |
48 | CSK | 1.07117251 |
49 | FGFR3 | 1.04154559 |
50 | CDC42BPA | 1.04118548 |
51 | PRKD1 | 1.02687582 |
52 | ILK | 1.02263401 |
53 | MAPKAPK3 | 1.01121820 |
54 | PDGFRA | 0.99669243 |
55 | STK4 | 0.99246107 |
56 | LIMK1 | 0.98152377 |
57 | PRKG2 | 0.98049506 |
58 | PIK3CA | 0.97170495 |
59 | PTK6 | 0.93356902 |
60 | JAK1 | 0.92546986 |
61 | LATS2 | 0.91881976 |
62 | MATK | 0.90395943 |
63 | RIPK4 | 0.89718959 |
64 | GRK5 | 0.88977025 |
65 | ICK | 0.88484916 |
66 | MAP4K1 | 0.86607136 |
67 | CAMK1D | 0.83657839 |
68 | MAPK12 | 0.83276840 |
69 | MET | 0.81018276 |
70 | MAP3K1 | 0.79465598 |
71 | MAP3K8 | 0.78487005 |
72 | NME2 | 0.77421548 |
73 | MUSK | 0.74140490 |
74 | ZAP70 | 0.73857324 |
75 | MAP3K10 | 0.72318713 |
76 | NEK1 | 0.70954254 |
77 | ABL2 | 0.69618030 |
78 | GRK1 | 0.69396870 |
79 | MAP3K5 | 0.69324108 |
80 | FLT3 | 0.68943820 |
81 | JAK3 | 0.67563672 |
82 | RPS6KA2 | 0.67284406 |
83 | CAMK4 | 0.66676194 |
84 | WNK1 | 0.64890356 |
85 | SIK3 | 0.62920378 |
86 | MAP3K9 | 0.62701877 |
87 | FGR | 0.61648731 |
88 | MAPK7 | 0.60853825 |
89 | HCK | 0.60179099 |
90 | EPHB2 | 0.59191847 |
91 | PIM2 | 0.58838143 |
92 | FGFR4 | 0.58384736 |
93 | IKBKB | 0.58289916 |
94 | EPHA2 | 0.57994583 |
95 | PTK2B | 0.55714459 |
96 | MAP3K12 | 0.55235922 |
97 | SCYL2 | 0.53713889 |
98 | JAK2 | 0.52182368 |
99 | STK3 | 0.50847999 |
100 | PDPK1 | 0.49589182 |
101 | MARK3 | 0.49287881 |
102 | PDGFRB | 0.49168900 |
103 | ROCK1 | 0.48127308 |
104 | IRAK3 | 0.47935516 |
105 | BCKDK | 0.47850133 |
106 | PRKD2 | 0.47646953 |
107 | ITK | 0.47559086 |
108 | DAPK3 | 0.47332501 |
109 | GRK6 | 0.46920201 |
110 | LATS1 | 0.46839758 |
111 | PRKAA2 | 0.44924200 |
112 | CDK6 | 0.44846114 |
113 | MELK | 0.44610644 |
114 | TAOK1 | 0.43139779 |
115 | EEF2K | 0.42329819 |
116 | FES | 0.42108478 |
117 | MAPKAPK2 | 0.42073981 |
118 | ROCK2 | 0.41990105 |
119 | EPHA3 | 0.41947564 |
120 | ERBB4 | 0.41813405 |
121 | MAP3K7 | 0.41569199 |
122 | CHUK | 0.41421695 |
123 | CDK9 | 0.41142077 |
124 | MST4 | 0.40670970 |
125 | MAP3K14 | 0.40206218 |
126 | BTK | 0.39698627 |
127 | PAK3 | 0.39396707 |
128 | MTOR | 0.39331359 |
129 | BMX | 0.38982200 |
130 | IKBKE | 0.38861161 |
131 | MAPK11 | 0.38332420 |
132 | MAP3K11 | 0.38152993 |
133 | RPS6KA4 | 0.38121353 |
134 | FER | 0.36839941 |
135 | PAK2 | 0.35780920 |
136 | RPS6KA6 | 0.35668428 |
137 | RPS6KL1 | 0.34625885 |
138 | RPS6KC1 | 0.34625885 |
139 | IRAK1 | 0.34578870 |
140 | TEC | 0.34290017 |
141 | HIPK2 | 0.31433536 |
142 | LCK | 0.30382443 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.41541134 |
2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.40404858 |
3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.35841525 |
4 | Viral myocarditis_Homo sapiens_hsa05416 | 2.56163072 |
5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.32844751 |
6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.15029757 |
7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.13232034 |
8 | Allograft rejection_Homo sapiens_hsa05330 | 2.11500374 |
9 | Leishmaniasis_Homo sapiens_hsa05140 | 1.91282070 |
10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.81931557 |
11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.79604801 |
12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.77842905 |
13 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.76127218 |
14 | Focal adhesion_Homo sapiens_hsa04510 | 1.74204876 |
15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.73165900 |
16 | Asthma_Homo sapiens_hsa05310 | 1.67690857 |
17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.65442612 |
18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64108535 |
19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62003041 |
20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.61426208 |
21 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.61269378 |
22 | Adherens junction_Homo sapiens_hsa04520 | 1.56088498 |
23 | Lysosome_Homo sapiens_hsa04142 | 1.56005105 |
24 | Bladder cancer_Homo sapiens_hsa05219 | 1.52908864 |
25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.46120810 |
26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.41069673 |
27 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.39379421 |
28 | Amoebiasis_Homo sapiens_hsa05146 | 1.32113191 |
29 | Malaria_Homo sapiens_hsa05144 | 1.31625417 |
30 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.30653356 |
31 | Pertussis_Homo sapiens_hsa05133 | 1.30534215 |
32 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.26741794 |
33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.25773627 |
34 | Platelet activation_Homo sapiens_hsa04611 | 1.20699906 |
35 | Salmonella infection_Homo sapiens_hsa05132 | 1.19256144 |
36 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.17623437 |
37 | Prion diseases_Homo sapiens_hsa05020 | 1.17511769 |
38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.17366805 |
39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.17297567 |
40 | Tuberculosis_Homo sapiens_hsa05152 | 1.16349425 |
41 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.15212294 |
42 | Insulin resistance_Homo sapiens_hsa04931 | 1.15064024 |
43 | Legionellosis_Homo sapiens_hsa05134 | 1.14674073 |
44 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.14168252 |
45 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.11317022 |
46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09771287 |
47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.09676340 |
48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.07055074 |
49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.05699079 |
50 | Apoptosis_Homo sapiens_hsa04210 | 1.04391972 |
51 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.02573202 |
52 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.02506720 |
53 | Measles_Homo sapiens_hsa05162 | 1.02191464 |
54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.01143206 |
55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99846728 |
56 | Influenza A_Homo sapiens_hsa05164 | 0.99296040 |
57 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.98549594 |
58 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.92990214 |
59 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.91493400 |
60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.88697711 |
61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88527728 |
62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86396140 |
63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86021496 |
64 | Phagosome_Homo sapiens_hsa04145 | 0.85758670 |
65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85579668 |
66 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.85166418 |
67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83988344 |
68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82058024 |
69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81322258 |
70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81285911 |
71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80883803 |
72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80790458 |
73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80353095 |
74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.79323582 |
75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79041069 |
76 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.78846468 |
77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.78817934 |
78 | Shigellosis_Homo sapiens_hsa05131 | 0.76803997 |
79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76622143 |
80 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.76179049 |
81 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.75526395 |
82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74546216 |
83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.74272497 |
84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74103465 |
85 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73817703 |
86 | Tight junction_Homo sapiens_hsa04530 | 0.72227868 |
87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71656123 |
88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71006357 |
89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69931416 |
90 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69720635 |
91 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68727424 |
92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68587153 |
93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66538737 |
94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65677714 |
95 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64455741 |
96 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.64316207 |
97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64243237 |
98 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.64140459 |
99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63239564 |
100 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.62523555 |
101 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.62016205 |
102 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60006077 |
103 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58590070 |
104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57356005 |
105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57235391 |
106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56686458 |
107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56436386 |
108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56217113 |
109 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.56058709 |
110 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.55322298 |
111 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54873130 |
112 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54731922 |
113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53890323 |
114 | Hepatitis B_Homo sapiens_hsa05161 | 0.52903020 |
115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52895480 |
116 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52634681 |
117 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51872182 |
118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50946847 |
119 | * Endocytosis_Homo sapiens_hsa04144 | 0.50698895 |
120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50533798 |
121 | Hepatitis C_Homo sapiens_hsa05160 | 0.49915685 |
122 | Alzheimers disease_Homo sapiens_hsa05010 | 0.49352986 |
123 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.49090189 |
124 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48201250 |
125 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47736153 |
126 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47021148 |
127 | Prostate cancer_Homo sapiens_hsa05215 | 0.46865717 |
128 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46147163 |
129 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.45802942 |
130 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.45777568 |